Smoking and T cell co-stimulation in rheumatoid arthritis by Wasén, Caroline
Göteborg, 2019 
 
   
SAHLGRENSKA AKADEMIN 
INSTITUTIONEN FÖR MEDICIN 
 
Smoking and T cell co-stimulation in rheumatoid arthritis 
Akademisk avhandling 
Som för avläggande av medicine doktorsexamen vid Sahlgrenska akademin, Göteborgs universitet 
kommer att offentligen försvaras i föreläsningssalen, våning 3, Guldhedsgatan 10A, Göteborg 
 
Fredagen den 10 maj 2019 klockan 9:00 
av 
Caroline Wasén  
 
Fakultetsopponent: 
Professor Bent Winding Deleuran 
Aarhus Universitet, Danmark 
 
Avhandlingen baseras på följande delarbeten: 
I. Wasén C, M Turkkila, A Bossios, M Erlandsson, KM Andersson, L Ekerljung, 
C Malmhäll, M Brisslert, S Töyrä Silfverswärd, B Lundbäck, and MI 
Bokarewa. Smoking activates cytotoxic CD8+ T cells and causes survivin 
release in rheumatoid arthritis. Journal of Autoimmunity 2017; 78: 101-10 
II. Wasén C, MC Erlandsson, A Bossios, L Ekerljung, C Malmhäll, S Töyrä 
Silfverswärd, R Pullerits, B Lundbäck, and MI Bokarewa. Smoking is 
associated with low levels of soluble PD-L1 in rheumatoid arthritis. 
Frontiers in Immunology 2018; 9(1677) 
III. Wasén C, C Ospelt, M Erlandsson, KME Andersson, S Töyrä Silfverswärd, M 
Brisslert, S Gay, MI Bokarewa. Nicotine changes microRNA profile to 
control the Foxo1 mediated memory program of CD8+ T cells in 
rheumatoid arthritis. Manuscript
Göteborg, 2019 
    
Smoking and T cell co-stimulation in rheumatoid arthritis 
Caroline Wasén 
Department of Rheumatology and Inflammation Research 
Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Sweden 2019 
ABSTRACT 
In this thesis I investigated if smoking limits the co-stimulatory system of CD8+ T cells in 
rheumatoid arthritis (RA). I took special interest in the co-inhibitory receptor PD-1 and its ligand 
PD-L1.  
Blood samples from RA patients with known smoking status and experimental models 
of RA (RA mice) in which orally administered nicotine simulated smoking were used. 
Additionally, CD8+ T cells were isolated from human blood and stimulated in vitro. Flow 
cytometry were used to analyze the expression of PD-1. ELISA was used to measure the soluble 
form of PD-L1 in serum samples from RA patients and healthy controls. Quantitative PCR was 
used for transcriptional analysis of proteins and microRNAs involved in CD8+ T cell regulation. 
Microarray analysis of microRNA was performed in samples of human CD8+ T cells.  
Smokers had fewer activated CD8+ T cells that expressed PD-1 compared to non-
smokers, and human CD8+ T cells stimulated with nicotine in vitro had lower expression of PD-
1 messengerRNA. RA mice treated with nicotine had fewer PD-1 expressing CD8+ T cells in the 
bone marrow. This was related to the increased production and release in circulation of the 
onco-protein survivin, a predictive marker for severe RA. CD8+ T cells of smokers adopted a 
naïve/memory phenotype and had different expression of several microRNA that are involved 
in the regulation of memory T cell formation, including the FOXO signaling pathway. Smokers 
also had lower levels of soluble PD-L1 in serum. The low PD-L1 levels were linked to altered 
expression of antibody receptors on antigen-presenting cells producing soluble PD-L1. The 
presence of RA-specific autoantibodies was associated with serum levels of soluble PD-L1.  
I conclude that smoking interferes with the PD-1 inhibitory system on CD8+ T cells, 
which may contribute to higher risk for RA in smokers. This can occur because of the reduced 
inhibitory control of the CD8+ T cells with low PD-1 expression, but also because of a reduced 
supply of sPD-L1. Furthermore, I suggest that microRNA interfere with the FOXO signaling 
pathway and influence the phenotype of CD8+ T cells in smokers. 
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